NPI: 1043371826 · TEMPE, AZ 85288 · 261QU0200X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 225,502 | $21.46M |
| 2019 | 234,282 | $21.92M |
| 2020 | 223,877 | $18.66M |
| 2021 | 256,423 | $22.86M |
| 2022 | 286,683 | $27.18M |
| 2023 | 258,736 | $26.57M |
| 2024 | 200,613 | $22.63M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | 716,337 | 685,615 | $70.64M | |
| 99213 | 435,340 | 421,508 | $45.68M | |
| 99203 | 294,319 | 286,542 | $29.68M | |
| 99204 | 141,986 | 138,324 | $14.61M | |
| 99212 | 3,062 | 2,942 | $315K | |
| 99202 | 2,575 | 2,539 | $253K | |
| 87426 | 21,855 | 20,822 | $39K | |
| U0002 | Covid-19 lab test non-cdc | 18,106 | 12,797 | $21K |
| 99215 | Prolong outpt/office vis | 167 | 164 | $17K |
| 99211 | 79 | 79 | $8K | |
| 99205 | Prolong outpt/office vis | 80 | 77 | $8K |
| 87880 | 5,602 | 5,058 | $4K | |
| 87804 | 4,323 | 2,169 | $3K | |
| 87811 | 51 | 38 | $1K | |
| 96372 | 1,429 | 1,195 | $851.73 | |
| 99000 | 28,967 | 21,790 | $695.54 | |
| 87635 | 3,458 | 3,319 | $396.05 | |
| 71046 | 91 | 89 | $246.51 | |
| 81003 | 2,241 | 2,050 | $227.02 | |
| J7510 | Prednisolone oral per 5 mg | 60 | 58 | $104.33 |
| 81025 | 103 | 102 | $15.50 | |
| J1885 | Ketorolac tromethamine inj | 171 | 166 | $15.49 |
| J1100 | Dexamethasone sodium phos | 56 | 55 | $12.83 |
| 36415 | 56 | 56 | $2.73 | |
| J0696 | Ceftriaxone sodium injection | 108 | 103 | $1.91 |
| 99051 | 5,248 | 3,518 | $0.00 | |
| S0119 | Ondansetron 4 mg | 25 | 23 | $0.00 |
| 73610 | 17 | 17 | $0.00 | |
| 73110 | 14 | 14 | $0.00 | |
| 73630 | 19 | 19 | $0.00 | |
| 73130 | 14 | 14 | $0.00 | |
| 94640 | 14 | 13 | $0.00 | |
| 93000 | 24 | 24 | $0.00 | |
| A9150 | Misc/exper non-prescript dru | 26 | 25 | $0.00 |
| 83036 | 31 | 30 | $0.00 | |
| 36416 | 18 | 18 | $0.00 | |
| A6449 | Lt compres band >=3" <5"/yd | 13 | 12 | $0.00 |
| J1030 | Methylprednisolone 40 mg inj | 13 | 13 | $0.00 |
| 82962 | 18 | 18 | $0.00 |